taxonomy (1)
protein (1)
source (3)
structure (19)
composition (31)
disease (2)
reference (4)
site (5)
peptide (8)
- Homo sapiens (Human)
Taxonomy
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
Source
- N-Linked / No-core / Man(a1-?)Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / No-core / Man(a1-?)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / No-core / Man(a1-?)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / No-core / Man(a1-?)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / No-core / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GlcNAc(b1-?)Man(a1-3)[GlcNAc(b1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
Reported structure
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:2 HexNAc:2 dHex:2 (avg mass : 1040.9761 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:2 dHex:2 (avg mass : 1203.1185 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:3 dHex:2 (avg mass : 1406.3135 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:4 dHex:2 (avg mass : 1609.5085 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 dHex:2 (avg mass : 1568.4559 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:4
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:9 HexNAc:8 NeuAc:1
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells. (2000 - Rudd P, Downing A, Cadene M, Harvey D, Wormald M, Weir I, Dwek R, Rifkin D, Gleizes P) / Status : Reviewed
Reference
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
Reported glycosite
-
- N-Linked / No-core (avg mass : 748.6901)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / No-core (avg mass : 894.8331)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / No-core (avg mass : 894.8331)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Pauci-Mannose (avg mass : 910.8325)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / No-core (avg mass : 1040.9761)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Pauci-Mannose (avg mass : 1056.9755)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Pauci-Mannose (avg mass : 1056.9755)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1114.0275)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Pauci-Mannose (avg mass : 1203.1185)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / No-core (avg mass : 1260.1705)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1260.1705)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1260.1705)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1276.1699)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1317.2225)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1406.3135)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1463.3655)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1463.3655)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1568.4559)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- N-Linked / Complex (avg mass : 1609.5085)
- BTI-Tn-5B1-4 (CVCL_C190) Egg Cell
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
-
- Hex:4 HexNAc:3 / N-Linked (avg mass : 1276.1699)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:4 HexNAc:5 / N-Linked (avg mass : 1682.5599)
- Blood Serum (UBERON_0001977)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTIISENGHAADTITATNFR (23aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
- ASGLGDHCEDINECLEDK (18aa)
-
- Hex:6 HexNAc:5 / N-Linked (avg mass : 2006.8447)
- Blood Serum (UBERON_0001977)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- YVQDQVAAPFQISNHTGR (18aa)
- GNTTTIISENGHAADTITATNFR (23aa)
- KECYYNINDASICDNVIAPNVTK (23aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- YVQDQVAAPFQISNHTGR (18aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- ASGLGDHCEDINECLEDK (18aa)
-
- Hex:5 HexNAc:4 dHex:4 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- YVQDQVAAPFQISNHTGR (18aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- QQLQGVNVCGGR (12aa)
- GNTTTLISENGHAADTLTATNFR (23aa)
-
- Hex:7 HexNAc:6 / N-Linked (avg mass : 2372.1821)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- KECYYNINDASICDNVIAPNVTK (23aa)
-
- Hex:6 HexNAc:7 / N-Linked (avg mass : 2413.2347)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- KECYYNINDASICDNVIAPNVTK (23aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- QQLQGVNVCGGR (12aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- YVQDQVAAPFQLSNHTGR (18aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- KECYYNINDASICDNVIAPNVTK (23aa)
-
- Hex:9 HexNAc:8 NeuAc:1 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Latent transforming growth factor beta binding protein 1 / Homo sapiens
- KECYYNINDASICDNVIAPNVTK (23aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
